Back
Defiance Nasdaq 100 Income Target ETF Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Sell
22
QQQT
Defiance Nasdaq 100 Income Target ETF
Last Price:
$17.96
Seasonality Move:
-13.24%
Buy
60
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$784.09
Seasonality Move:
12.13%
Sell
22
Defiance Nasdaq 100 Income Target ETF (QQQT)
is a Sell
Is Defiance Nasdaq 100 Income Target ETF a Buy, Sell or Hold?
-
The current Defiance Nasdaq 100 Income Target ETF [QQQT] share price is $17.96. The Score for QQQT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
QQQT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $783.71. The Score for REGN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QQQT Stock Price Chart
What is Defiance Nasdaq 100 Income Target ETF's stock price today?
-
The Defiance Nasdaq 100 Income Target ETF share price today is $17.96Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QQQT is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $783.71Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
QQQT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.39 | Buy |
| Relative Strength Index (14 RSI): | 51.16 | Buy |
| Chaikin Money Flow: | 26513 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.61 - 18.11) | Buy |
| Bollinger Bands (100): | (17.82 - 18.5) | Sell |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 204.17 | Buy |
| Relative Strength Index (14 RSI): | 67.2 | Buy |
| Chaikin Money Flow: | -261329 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (720.67 - 774.53) | Buy |
| Bollinger Bands (100): | (555.56 - 709.04) | Buy |
QQQT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.7 | Buy |
| 20-day SMA: | 17.93 | Buy |
| 50-day SMA: | 18.14 | Sell |
| 200-day SMA: | 17.64 | Buy |
| 8-day EMA: | 12.71 | Buy |
| 20-day EMA: | 6.98 | Buy |
| 50-day EMA: | 3.21 | Buy |
| 200-day EMA: | 0.86 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 764.21 | Buy |
| 20-day SMA: | 747.28 | Buy |
| 50-day SMA: | 691.09 | Buy |
| 200-day SMA: | 601.8 | Buy |
| 8-day EMA: | 603.24 | Buy |
| 20-day EMA: | 348.3 | Buy |
| 50-day EMA: | 164.33 | Buy |
| 200-day EMA: | 44.8 | Buy |
Defiance Nasdaq 100 Income Target ETF Earnings Growth & QQQT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.
Defiance Nasdaq 100 Income Target ETF Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||